Melanoma is a type of cancer that originates from melanocytes, the cells responsible for producing skin pigment, and is known ...

Key mechanism of resistance to BRAF-targeted melanoma therapy discovered. Potential for developing new cancer therapies with high efficacy by regulating polyamine biosynthesis to suppress resistance.

Anchor] Melanoma, a type of skin cancer, has a mortality rate of more than 70%, but anticancer drugs currently used in ...

gordonii releases a substance called ornithine that prompts F. nucleatum to produce a molecule called polyamine in larger quantities. Since F. nucleatum requires methionine to produce polyamine, this ...

Yilmaz also noted that the regenerative benefits of fasting could be significant for people who undergo radiation treatment, which can damage the intestinal lining, or other types of intestinal injury ...

Juan-Manuel Schvartzman, MBBCh, PhD, is assistant professor of medicine at Columbia University Vagelos College of Physicians ...

The global fixing agent industry size was worth USD 2.97 Billion in the year 2021 and is expected to reach USD 5.24 Billion ...

GlobalData’s report assesses the drugs in the Ornithine Decarboxylase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the first patient ...